Kølner-Augustson, L.; Altraja, A.; Bendstrup, E.; Bradding, P.; Makholm, N.; Wilson, A.M.; Simonsen, U.; Hilberg, O.
Senicapoc in Patients with Idiopathic Pulmonary Fibrosis or Other Progressive Fibrotic Interstitial Lung Diseases: Protocol for a Randomised, Double-Blind, Placebo-Controlled, Multicentre Phase II Trial. Diagnostics 2026, 16, 1649.
https://doi.org/10.3390/diagnostics16111649
AMA Style
Kølner-Augustson L, Altraja A, Bendstrup E, Bradding P, Makholm N, Wilson AM, Simonsen U, Hilberg O.
Senicapoc in Patients with Idiopathic Pulmonary Fibrosis or Other Progressive Fibrotic Interstitial Lung Diseases: Protocol for a Randomised, Double-Blind, Placebo-Controlled, Multicentre Phase II Trial. Diagnostics. 2026; 16(11):1649.
https://doi.org/10.3390/diagnostics16111649
Chicago/Turabian Style
Kølner-Augustson, Line, Alan Altraja, Elisabeth Bendstrup, Peter Bradding, Nanna Makholm, Andrew M. Wilson, Ulf Simonsen, and Ole Hilberg.
2026. "Senicapoc in Patients with Idiopathic Pulmonary Fibrosis or Other Progressive Fibrotic Interstitial Lung Diseases: Protocol for a Randomised, Double-Blind, Placebo-Controlled, Multicentre Phase II Trial" Diagnostics 16, no. 11: 1649.
https://doi.org/10.3390/diagnostics16111649
APA Style
Kølner-Augustson, L., Altraja, A., Bendstrup, E., Bradding, P., Makholm, N., Wilson, A. M., Simonsen, U., & Hilberg, O.
(2026). Senicapoc in Patients with Idiopathic Pulmonary Fibrosis or Other Progressive Fibrotic Interstitial Lung Diseases: Protocol for a Randomised, Double-Blind, Placebo-Controlled, Multicentre Phase II Trial. Diagnostics, 16(11), 1649.
https://doi.org/10.3390/diagnostics16111649
